[Partial synchronization of cells in experimental leukemia L 5222 in rats].
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
B Barlogie
Publications and source records attributed to B Barlogie.
[Proliferation kinetics of leukemias before and during therapy as based on impulse cytophotometry].
Explore the source record for details and available documents.
Cell Division↗
Activation of calcium efflux by ADP and inorganic phosphate.
Explore the source record for details and available documents.
Journal Article↗
Genotypic and phenotypic characteristics of multiple myeloma.
Explore the source record for details and available documents.
Antigens, Differentiation↗
High dose melphalan for refractory myeloma--the M.D. Anderson experience.
Explore the source record for details and available documents.
Antineoplastic Combined Chemotherapy Protocols↗
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
Forty-nine patients with metastatic or recurrent renal cell carcinoma were treated on a phase II trial of Echinomycin. Treatment consisted of Echinomycin 1.25 mg/m2 intravenously every 28 days. Among the 47 evaluable patients there were no complete responses and only one partial response for an overall response rate of 2% (95% confidence interval, 0-11%). Eighteen patients (38%) experienced toxicity of grade 3 or worse. The most common toxicities were nausea and vomiting. The results of this study indicate that Echinomycin is not sufficiently active to warrant further trials for the treatment of renal cell carcinoma.
Adult↗
[Plasma-cell myeloma. II. New developments in the diagnosis and treatment of the disease].
Explore the source record for details and available documents.
Antineoplastic Combined Chemotherapy Protocols↗
Lethal and kinetic response of cultured human lymphoid cells to melphalan.
Explore the source record for details and available documents.
Cell Division↗